biotin has been researched along with Minimal Disease, Residual in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axtman, A; Bäck, T; Fisher, DR; Frayo, S; Gopal, AK; Green, DJ; Hamlin, DK; Kenoyer, AL; Lin, Y; Orgun, N; Pagel, JM; Park, SI; Press, OW; Shenoi, J; Wilbur, DS | 1 |
| Bartram, CR; Erz, DH; Hansen-Hagge, TE; Seriu, T | 1 |
| Ellison, DJ; Leopard, JD; Piro, LD; Robbins, BA; Saven, A; Sharpe, RW; Spinosa, JC | 1 |
1 trial(s) available for biotin and Minimal Disease, Residual
| Article | Year |
|---|---|
Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.
Topics: Alleles; Base Sequence; Biotin; Child; Clone Cells; DNA Primers; Gene Rearrangement, delta-Chain T-Cell Antigen Receptor; Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor; Humans; Molecular Sequence Data; Neoplasm Proteins; Neoplasm, Residual; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Receptors, Antigen, T-Cell, gamma-delta; Sensitivity and Specificity; T-Lymphocytes | 1995 |
2 other study(ies) available for biotin and Minimal Disease, Residual
| Article | Year |
|---|---|
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease.
Topics: Animals; Antibodies, Neoplasm; Antigens, CD20; Biotin; Bismuth; Blood Cell Count; Cell Line, Tumor; Humans; Immunoglobulin Variable Region; Kidney; Liver Function Tests; Lymphoma, Non-Hodgkin; Mice; Neoplasm, Residual; Organometallic Compounds; Radioimmunotherapy; Radiometry; Recombinant Fusion Proteins; Survival Analysis; Tissue Distribution; Xenograft Model Antitumor Assays | 2010 |
Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia.
Topics: Antibodies, Monoclonal; Antibody Specificity; Avidin; B-Lymphocyte Subsets; Biopsy, Needle; Biotin; Bone Marrow; Bone Marrow Examination; Cell Membrane; Cell Nucleus; Cladribine; Cytoplasmic Granules; False Negative Reactions; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia, Hairy Cell; Neoplasm, Residual; Neoplastic Stem Cells; Remission Induction | 1994 |